Status:

ENROLLING_BY_INVITATION

Capsule Endomicroscopy for Visualization of the Small Intestine in EED Population in Pakistan

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

Bill and Melinda Gates Foundation

Aga Khan University Hospital, Pakistan

Conditions:

Environmental Enteric Dysfunction

Eligibility:

All Genders

6-70 years

Phase:

NA

Brief Summary

This pilot study will test the feasibility and tolerability of the tethered OCT capsule and Trans Nasal Endomicroscopy probe and accessory devices for imaging the small intestine in subjects with EED ...

Detailed Description

Environmental enteric dysfunction (EED) is a poorly understood condition characterized by intestinal inflammation and loss of barrier function that is prevalent in regions of the world with inadequate...

Eligibility Criteria

Inclusion

  • The
  • Children must be 6 months to 59 months old
  • Adult subjects 18 years of age or older scheduled for a standard of care endoscopy
  • EED manifesting as malnourishment (WHZ\<-2) without clear etiology or healthy subjects with WHZ \>=0
  • Subjects and/or parents/guardians must be able to give informed consent/assent
  • Subjects and/or parents/guardians must be willing to provide consent for live streaming of the procedure
  • Subjects must be able to follow fasting instructions prior to the procedure
  • Inclusion criteria for Pregnant women:
  • Subjects 18 years and older
  • Subjects who are in their 2nd trimester of singleton pregnancy as confirmed by an ultrasound
  • Subjects with a BMI below 18.5 without clear etiology and healthy pregnant women with BMI between 18.5 -24.5.
  • Subjects must be able to follow fasting instructions prior to the procedure
  • Subjects must be able to consent to the procedure
  • Tethered Capsule

Exclusion

  • Subjects with any history of esophageal or intestinal strictures or prior GI surgery
  • Subjects with history of pyloric stenosis
  • Subjects with HIV diagnosis
  • Trans Nasal

Key Trial Info

Start Date :

October 11 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2029

Estimated Enrollment :

170 Patients enrolled

Trial Details

Trial ID

NCT04275167

Start Date

October 11 2017

End Date

January 1 2029

Last Update

May 13 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aga Khan Medical Center

Karachi, Pakistan